(DNT) TYLENOL FIGHTS LABEL CHANGE; WHAT PARENTS NEED TO KNOW

Kenvue, the American drugmakers that produces Tylenol, is pushing back on proposed changes to the product’s safety label about a possible connection between its use in pregnancy and diagnoses of autism or ADHD in children. The push for a label change came last month after a press conference where President Trump urged pregnant women to try to “tough it out” instead of taking Tylenol.” In a statement, Kenvue said that acetaminophen, the generic name for Tylenol, was “one of the most studied medicines in history” and that “scientific evidence does not support a causal association between acetaminophen use in pregnancy and neurodevelopmental disorders.” But what do people who are expecting a child need to know about the controversy? According to Dr. Brian Lee, a professor of epidemiology and biostatistics at Drexel University, while there is no debate that “rates of autism diagnoses are increasing” a study published last year in JAMA found that “there was no increase in risk of autism or ADHD associated with acetaminophen use.” Correspondent Ivan Rodriguez has all the details in a 3pET PKG with FREE custom talkbacks from Atlanta.